Clinical Trials Logo

Benign Hepatobiliary Disease clinical trials

View clinical trials related to Benign Hepatobiliary Disease.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04445532 Recruiting - Clinical trials for Hepatocellular Carcinoma

Hepatobiliary Tumors Tissue Samples Acquisition

Start date: October 11, 2020
Phase:
Study type: Observational

Hepatobiliary tumors have a poor prognosis and high individual heterogeneity, so it is of great significance to find important prognostic markers and then screen out specific subgroups of people; meanwhile, chronic hepatitis, cirrhosis, and healthy control participants also need to show the evolution of tumors and discover specific diagnostic markers as a control group. Moreover, targeted therapy and immunotherapy make cancer treatment enter a new field, but only part of patients achieve response rates and reach clinical benefit. However, these drugs are expensive and can cause treatment-related adverse events. Therefore, reliable biomarkers identification is needed to help predict the response to these treatment options in order to screen patients with better responsiveness and avoid wasting money. Multi-omics research can reveal the characteristics of hepatobiliary tumors more deeply and find meaningful therapeutic targets. Therefore, 450 patients at least 18 years of age with hepatobiliary tumors were included in this study.